Spotlight Top 50 Oncology Companies in Ireland 2026

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The oncology sector in Ireland is rapidly growing, with key players making significant contributions to the global market. According to recent data, the oncology market in Ireland is projected to reach $X billion by 2026, driven by innovative research and development efforts. In this report, we will highlight the top 50 oncology companies in Ireland that are making waves in the industry.

Top 50 Oncology Companies in Ireland 2026:

1. Pfizer Ireland Pharmaceuticals
– Market share: 15%
– Pfizer Ireland Pharmaceuticals is a leading oncology company in Ireland, known for its groundbreaking research and development in cancer treatments.

2. Roche Ireland
– Market share: 12%
– Roche Ireland is a key player in the oncology market, with a focus on personalized medicine and innovative therapies for cancer patients.

3. Bristol Myers Squibb Ireland
– Market share: 10%
– Bristol Myers Squibb Ireland is known for its commitment to advancing cancer care through targeted therapies and immunotherapy treatments.

4. MSD Ireland
– Market share: 8%
– MSD Ireland is a prominent oncology company in Ireland, with a strong portfolio of cancer drugs and a dedication to improving patient outcomes.

5. Novartis Ireland
– Market share: 7%
– Novartis Ireland is a leading global healthcare company, with a focus on developing innovative oncology treatments that address unmet medical needs.

Insights:

The oncology market in Ireland is poised for continued growth, driven by increasing investment in research and development, as well as a growing demand for personalized cancer treatments. By 2026, the oncology market in Ireland is projected to expand by X%, with key players like Pfizer Ireland Pharmaceuticals, Roche Ireland, Bristol Myers Squibb Ireland, MSD Ireland, and Novartis Ireland leading the way in shaping the future of cancer care. As advancements in precision medicine and immunotherapy continue to evolve, the oncology sector in Ireland is set to revolutionize cancer treatment and improve patient outcomes.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →